Latest Articles
GSK’s New Clinical Study on Endometrial Cancer: What Investors Need to Know - TipRanks
GSK’s New Clinical Study on Endometrial Cancer: What Investors Need to Know TipRanks
Published: Aug. 7, 2025, 4:23 p.m.
Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer - TipRanks
Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer TipRanks
Published: Aug. 7, 2025, 4:18 p.m.
Dietary and lifestyle strategies for endometrial cancer prevention: Emerging evidence and unanswered questions - EurekAlert!
Dietary and lifestyle strategies for endometrial cancer prevention: Emerging evidence and unanswered questions EurekAlert!
Published: Aug. 7, 2025, 3:02 p.m.
Immunotherapy plus chemotherapy approved for endometrial cancer - The Pharmaceutical Journal
Immunotherapy plus chemotherapy approved for endometrial cancer The Pharmaceutical Journal
Published: Aug. 7, 2025, 2:48 p.m.
I’ve been waiting a year for endometriosis diagnosis - I'm scared I'll lose my job - The i Paper
I’ve been waiting a year for endometriosis diagnosis - I'm scared I'll lose my job The i Paper
Published: Aug. 7, 2025, noon
How a Four-Day Retreat Helped Me Make Peace with My Endometriosis - Popsugar UK
How a Four-Day Retreat Helped Me Make Peace with My Endometriosis Popsugar UK
Published: Aug. 7, 2025, 11:58 a.m.
PHAM Launches Ontario's First-Ever Endo Road Show - The Globe and Mail
PHAM Launches Ontario's First-Ever Endo Road Show The Globe and Mail
Published: Aug. 7, 2025, 11:13 a.m.
PHAM Launches Ontario's First-Ever Endo Road Show - PR Newswire Canada
PHAM Launches Ontario's First-Ever Endo Road Show PR Newswire Canada
Published: Aug. 7, 2025, 11:13 a.m.
NICE backs KEYTRUDA combination for advanced endometrial cancer - PharmaTimes
NICE backs KEYTRUDA combination for advanced endometrial cancer PharmaTimes
Published: Aug. 7, 2025, 9:15 a.m.
Toxicity and Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer: A Real-World Retrospective Analysis - Frontiers
Toxicity and Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer: A Real-World Retrospective Analysis Frontiers
Published: Aug. 7, 2025, 7:56 a.m.
Link copied to clipboard!